PAMS
ISEE

Pictet Asset Management (Switzerland)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$982K Sell
24,966
-2,291,334
-99% -$80.9M ﹤0.01% 992
2023
Q1 		$56.4M Buy
2,316,300
+2,302,337
+16,489% +$50.4M 0.07% 265
2022
Q4 		$299K Buy
+13,963
New +$298K ﹤0.01% 1499

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ISEE Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its IVERIC bio, Inc. Common Stock (ISEE) stake by 99% in Q2 2023, selling an estimated $80.9M and leaving 24,966 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Pictet Asset Management (Switzerland) first reported a position in ISEE in Q4 2022 and has held it in 3 quarters since. The position peaked at $56.4M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 24,966 shares of IVERIC bio, Inc. Common Stock worth $982K as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 2,291,334 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $80.9M.
  • IVERIC bio, Inc. Common Stock made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #992 holding.
  • Pictet Asset Management (Switzerland) first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and has held it in 3 quarters since.
  • Pictet Asset Management (Switzerland)'s IVERIC bio, Inc. Common Stock position peaked at $56.4M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.